Despite apparently discrepant AKI outcomes in global vs. myeloid cell-specific IL-1R1 knockout mouse strains, both models provide conceptual support for pharmacological suppression of IL-1 signaling in AKI. This evidence concerns the gene IL1R1 and acute kidney injury.